Summa Equity , the purpose-driven private equity firm that invests to solve global challenges, has acquired a majority stake in Sengenics , a functional proteomics company with a proprietary technology called KREX that enables researchers to vastly improve the understanding of the human proteome and immune system. Proteomics, i.e. the large-scale study of proteins, is one of the most important areas for gaining insights into h
October 14, 2020
· 4 min read